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Abstract
Purpose: Attenuation correction (AC) based on low-dose computed tomography (CT) could be more accurate in brain
single-photon emission computed tomography (SPECT) than the widely used Chang method, and, therefore, has the
potential to improve both semi-quantitative analysis and visual image interpretation. The present study evaluated CT-based
AC for dopamine transporter SPECT with I-123-ioflupane.
Materials and methods: Sixty-two consecutive patients in whom I-123-ioflupane SPECT including low-dose CT had been
performed were recruited retrospectively at 3 centres. For each patient, 3 different SPECT images were reconstructed:
without AC, with Chang AC and with CT-based AC. Distribution volume ratio (DVR) images were obtained by scaling voxel
intensities using the whole brain without striata as reference. For assessing the impact of AC on semi-quantitative analysis,
specific-to-background ratios (SBR) in caudate and putamen were obtained by fully automated SPM8-based region of
interest (ROI) analysis and tested for their diagnostic power using receiver-operator-characteristic (ROC) analysis. For
assessing the impact of AC on visual image reading, screenshots of stereotactically normalized DVR images presented in
randomized order were interpreted independently by two raters at each centre.
Results: CT-based AC resulted in intermediate SBRs about half way between no AC and Chang. Maximum area under the
ROC curve was achieved by the putamen SBR, with negligible impact of AC (0.924, 0.935 and 0.938 for no, CT-based and
Chang AC). Diagnostic accuracy of visual interpretation also did not depend on AC.
Conclusions: The impact of CT-based versus Chang AC on the interpretation of I-123-ioflupane SPECT is negligible.
Therefore, CT-based AC cannot be recommended for routine use in clinical patient care, not least because of the additional
radiation exposure.
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Introduction
Single photon emission computed tomography (SPECT) with I-
123-labelled cocaine ligands for the presynaptic dopamine
transporter (DAT) is widely used for the diagnosis of Parkinsonian
syndromes and for differentiation between Alzheimer’s and Lewy
body disease [1–8]. It is also used for monitoring progression of
presynaptic dopaminergic degeneration [9]. The interpretation of
DAT SPECT is based on visual evaluation of the images
supported by semi-quantitative analysis [10–16] both of which
are affected by photon attenuation in the head [17].
There are several methods for attenuation correction (AC) in
brain SPECT. The most widely used method, proposed by Chang
[18], is based on post-processing of images reconstructed without
attenuation correction. However, this method has three limita-
tions. First, delineation of the outer contour of the head is required
which is prone to errors in case of both manual and automatic
threshold-based methods [19]. Second, Chang’s method assumes a
uniform attenuation coefficient throughout the whole head which
is an approximation only. Third, it is an approximation even if the
actual attenuation coefficient is uniform. It is strictly correct only
for a point source (at least in its non-iterative form).
Errors associated with these limitations of the Chang AC might
be avoided by modelling attenuation within the reconstruction
process using the correct attenuation map, for example measured
by low-dose x-ray computed tomography (CT). Whereas CT-
based AC has become standard in positron emission tomography
(PET) of the brain, it is not widely used in brain SPECT, despite
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the increasing availability of dual-modality SPECT/CT systems.
CT-based AC could provide more accurate AC than the Chang
method and, therefore, has the potential to improve both semi-
quantitative analysis and visual interpretation of DAT SPECT.
The aim of the present study was to compare CT-based AC and
Chang AC in dopamine transporter SPECT with N-v-fluoropro-
pyl-2b-carbomethoxy-3b-(4-I-123-iodophenyl)nortropane (I-123-
ioflupane). The impact of the AC method was assessed on both
semi-quantitative analysis and visual evaluation of the SPECT
images by independent readers blinded for clinical information.
Materials and Methods
1. Phantom studies
SPECT/CT of an anthropomorphic phantom for quantitative
SPECT and PET imaging of the striatum (Striatal Phantom,
Alderson, Radiology Support Devices Inc., Long Beach, CA,
USA) was performed at each of 3 centers (Berlin, Leipzig,
Rostock). The striata were filled symmetrically with about 40 kBq/
ml I-123 solution. The background was filled with about 5 kBq/ml.
Actual activity concentrations in striatum and background were
determined by measuring aliquots in a well counter.
2. Subjects
The study included 62 patients who had received SPECT with
I-123-ioflupane including low-dose CT in clinical routine patient
care for the diagnosis of a Parkinsonian syndrome (Berlin n= 21,
Leipzig n= 22 and Rostock n= 19). Consecutive patients were
included at each centre without any further inclusion or exclusion
criteria.
3. Ethics statement
The protocol of this retrospective study had been approved by
the Ethics Committee at Rostock University Medical Centre
(reference number A 2013-0144) and the Ethics Committee at
Charite´ University Medical Centre Berlin (reference number
EA1/326/13). The protocol complied with the Declaration of
Helsinki. All patients had given written consent for retrospective
analyses of their data.
4. SPECT imaging
SPECT imaging including low-dose CT had been performed
with a Symbia T6 dual-head SPECT/CT system equipped with
low energy high resolution parallel-hole collimators at each centre.
The acquisition protocol, based on procedure guidelines for I-123-
labelled dopamine transporter ligands and the ENC-DAT study
[11,20,21], was the same at each centre except for small
differences in the energy window at the I-123 peak and the two
additional energy windows for scatter correction (SC; energy
windows in keV: Berlin [141.66, 173.14], [130.64 141.66],
[173.14, 182.58], Leipzig: [147.07, 170.93], [123.22, 147.07],
[170.93, 194.77], Rostock: [140.91, 172.91], [129.95, 140.91],
[172.23, 181.62]). These differences were taken into account by
adjustment of the weight factors during scatter correction (s.
below).
Patients did not use medication or drugs known to strongly
interact with I-123-ioflupane SPECT [22,23]. 150 to 200 MBq I-
123-ioflupane were injected intravenously as a slow bolus after
blocking the thyroid gland by oral administration of perchlorate.
SPECT imaging was started between 3 and 4 hours post injection.
The rotation radius was adjusted for each patient so that
collimator-patient distance was as small as possible. The duration
of the SPECT acquisition was 30 minutes (step-and-shoot mode,
matrix 1286128, angular range 180u, angular sampling 3u, zoom
1.23). A low-dose CT was performed immediately after the
SPECT (130 keV, 50 mAs, 3 mm slice thickness).
The anonymized raw data from all centres were transferred to
one centre (Berlin) for centralized image reconstruction and
processing. Transversal images were reconstructed using the 3D
ordered-subset expectation-maximisation algorithm ‘Flash-3D’
provided by the Siemens scanner software (15 subsets and 6
iterations) [24–26]. Flash-3D allows CT-based AC, uniform AC
according to Chang and no AC. Spatial resolution in the
reconstructed images was about 8 mm full-width-at-half-maxi-
mum, voxel size was 3.963.963.9 mm3.
For conversion of Hounsfield units to linear attenuation
coefficients (LAC) in CT-based AC, the narrow-beam LAC of
m=0.148 cm21 was assumed for soft tissue, because SC using the
triple energy window approach implemented in the scanner
software was applied in all cases [27]. In order to achieve best
comparability between Chang and CT-based AC, Chang AC was
performed with the same LAC, i.e. m=0.148 cm21. For Chang
AC, the threshold-based automatic delineation of the head
contour implemented in the system software was used. The
threshold was optimized in each individual patient so that the best
match with the outer contour of the scalp was obtained according
to visual inspection.
Image reconstruction without AC, with CT-based AC and
Chang AC for each patient resulted in a total of 3 N 62=186
SPECT images.
5. Data evaluation
The impact of the AC method was assessed on both semi-
quantitative analysis and visual evaluation of the SPECT images.
5.1. Impact on semi-quantitative analysis. For semi-
quantitative assessment of DAT availability, the I-123-ioflupane
SPECT image of each individual patient was stereotactically
normalized into the anatomical space of the Montreal Neurolog-
ical Institute (MNI) using the normalization tool of the freely
available Statistical Parametric Mapping software package SPM
(version SPM8, Wellcome Trust Centre for Neuroimaging,
Institute of Neurology, UCL, London, UK) [28] and a custom-
made tracer-specific template (Fig. 1). The stereotactically nor-
malized I-123-ioflupane uptake image was scaled to the 75th
percentile of the voxel intensities in the whole brain without striata
as reference region (Fig. 1), i.e. the intensity value of each voxel
was divided by the 75th percentile of the voxel intensities in the
reference region [29]. The voxel intensity of the scaled SPECT
image represents the distribution volume ratio (DVR) as semi-
quantitative measure for local DAT availability.
Figure 1. Custom-made I-123-ioflupane template. Transversal
slice (left). ROIs for left/right caudate and putamen used for hottest
voxel analysis, and ROI for the reference region used for intensity
scaling, all defined in MNI space (middle). The union of caudate and
putamen ROI was used as ROI for the whole striatum. Fusion image
(right).
doi:10.1371/journal.pone.0108328.g001
DaTscan: CT-Based Attenuation Correction
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The DVRs in caudate and putamen were obtained by ‘hottest
voxel analysis’ in large predefined ROIs for left/right caudate and
left/right putamen in MNI space (Fig. 1). The number of hottest
voxels to be averaged was fixed to a total volume of 5 ml for the
caudate and 10 ml for the putamen. The DVR of the whole
striatum was obtained by averaging over the 15 ml hottest voxels
in the union of the caudate and the putamen ROI. DVRs were
converted to specific binding ratios (SBR) according to the formula
SBR=DVR –1. The SBR may be considered an estimate of the
nondisplaceable binding potential and, therefore, to be propor-
tional to the density of DAT available for binding of I-123-
ioflupane [30].
Caudate-to-putamen ratio ( = SBRcaudate/SBRputamen) and left/
right asymmetry (asym(%) = 200 N abs[(SBRleft 2 SBRright)/
(SBRleft+SBRright)]) were considered in addition to SBRs.
5.2. Impact on visual scoring. For retrospective visual
interpretation of the SPECT images, a pdf document was
prepared with 186 pages, one page for each SPECT image
(Fig. 2 a). The SPECT images were anonymized and presented in
randomized order. To guarantee comparable display conditions,
the upper threshold of the colour table was adjusted separately for
each AC method. For Chang AC, the upper threshold of the
colour table was set to 5.50. For CT-based AC, the upper
threshold of the colour table was scaled by the DVR of the caudate
(mean over left and right hemisphere) averaged over all patients,
i.e. threshold(CT) = avgDVR(CT)/avgDVR(Chang) N threshold(-
Chang), analogously for no AC. The lower threshold of the colour
table was set to one-tenth of the upper threshold in all cases.
Visual scoring of DAT availability was performed on a patient
base referring to Benamer et al. [31] using the following 5-score:
– ‘normal’: clear delineation of the whole striatum on both sides,
some minor global reduction of tracer uptake is allowed as well
as some minor left/right asymmetry (‘only big effects indicate
pathology’)
– ‘reduced type 1’: distinct reduction in the putamen in one
hemisphere (‘big’ effect), the striatum in the other hemisphere
still more or less normal
– ‘reduced type 2’: distinct reduction in both putamina, still some
uptake in the caudate nuclei
– ‘reduced type 3’: essentially no uptake in both striata
– ‘reduced other’: clear reduction of tracer uptake, but the
pattern does not match type 1, 2 or 3. This category was added
to the Benamer scheme in order to account for atypical
patterns, for example due to vascular pathology
The examples shown in Fig. 2 b were provided to the raters.
The certainty with respect to the differentiation between normal
and reduced (including all types of reduction) was scored in
addition to DAT availability. A 5-score was used ranging from
1= ‘very sure’ to 5 = ‘very unsure‘.
Image quality was scored from 1= ‘very good‘ to 5= ‘very bad‘
using the anatomical delineation of the striata and the level of
statistical noise in the background as criteria.
Visual scoring was performed by two independent raters at each
of the 3 centres (image quality in Leipzig only). In addition, the
two raters at each centre reached a consensus with respect to DAT
availability in those cases in which they had disagreed.
Figure 2. Example page from the pdf document for visual scoring. The pdf document comprised one page for each I-123-ioflupane SPECT
image showing a 12 mm thick slab (a, left) and 4x4 slices of 4 mm thickness (a, right). Example I-123-ioflupane SPECTs used as reference images for
the visual scoring (b).
doi:10.1371/journal.pone.0108328.g002
DaTscan: CT-Based Attenuation Correction
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6. Statistical methods
Statistics were performed with IBM SPSS Statistics (version 21,
IBM Corp., Armonk, NY, USA).
Concerning the results of the semi-quantitative analysis, the
effect of the AC method on the SBRs, left/right asymmetries and
caudate-to-putamen ratio was first assessed by Bland-Altman plots
[32]. Then the impact of AC on the diagnostic power of the semi-
quantitative parameters was tested using receiver-operator char-
acteristic (ROC) analysis. The classification of DAT availability in
the written report in the patient’s file served as gold standard (22
patients with normal DAT availability, 40 patients with reduced
DAT availability). The area under the ROC curve (AUC) was
used as performance measure. Multiple binary logistic regression
(forward conditional) was performed to analyze the diagnostic
power of combinations of SBR, asymmetry and caudate-to-
putamen ratio. Only the putamen SBR was included in the
multiple regression analysis, since there was a strong correlation
between caudate and putamen SBR (Pearson correlation coeffi-
cient = 0.87, p = 0.000, Chang AC) so that it was not advisable to
include both as independent parameters. The putamen SBR was
selected, because it showed higher diagnostic power than the
caudate SBR in the univariate ROC analyses.
Concerning the results of the visual reading, inter-rater
agreement was quantified by Cohen’s unweighted k [33], both
for the full 5-score for DAT availability and the binary score
derived from the 5-score by subsuming ‘reduced type 1, 2, 39 and
‘reduced other’ into one single category ‘reduced’. Agreement was
assessed between the 6 raters and between the 3 consensus scores.
Diagnostic accuracy of the visual scoring was characterized by the
% agreement with the gold standard.
The effect of the AC method on the certainty in differentiation
between normal and reduced DAT availability as well as on image
quality was tested by the general linear model for repeated
measures. The DAT availability (normal or reduced) according to
the report was added to the model as within-subject factor.
Potential covariates such as age or body mass index were not
taken into account [34].
Results
1. Impact on semi-quantitative analysis
Results of the semi-quantitative analysis of the phantom and
patient studies are summarized in Table 1 and Table 2, respec-
tively.
In the phantom studies, the actual SBR was strongly
underestimated in all cases, by about 57%, 52% and 48% with
no, CT-based and Chang AC (Table 1), i.e. CT-based AC
resulted in intermediate SBRs about half way between no AC and
Chang AC.
The latter was confirmed in the patient studies (Table 2, Fig. 3).
Chang AC resulted in an overestimation of the caudate SBR
compared to CT-based AC that was increasing with increasing
SBR (Fig. 3 a). The mean difference (CT-based – Chang) was 2
0.44560.188 (one sample t-test for zero mean: p,0.0005). The
mean difference of the putamen SBR was 20.11760.100 (p,
0.0005). The mean difference of left/right asymmetry in the
caudate was 1.6664.94% (p= 0.011), in the putamen
0.4167.16% (p= 0.652), and in the whole striatum 1.6064.79%
(p= 0.011). The mean difference of the caudate-to-putamen ratio
was 20.1560.15 (p,0.0005).
Univariate analysis of variance with the SBR (minimum over
both hemispheres) as dependent variable and region of interest
(caudate, putamen), DAT status (normal or reduced according to
the written report in the patient’s file) and centre (Berlin, Leipzig,
Rostock) as fixed factors revealed highly significant effects of the
region of interest and DAT status (both p,0.0005), whereas there
was no centre effect, independent of the AC method.
ROC curves for the differentiation between reduced and
normal DAT availability by the SBRs are shown in Fig. 4. The
putamen provided larger AUC than the caudate. The impact of
AC on the AUC was very small: AUC for the caudate 0.892 versus
0.886 versus 0.887, and for the putamen 0.924 versus 0.935 versus
0.938 for no AC, CT-based AC and Chang AC, respectively.
Asymmetries and caudate-to-putamen ratio provided less diag-
nostic power than the SBR (AUC #0.875).
The binary regression model included only the putamen SBR
(minimum over both hemispheres). The asymmetry of the SBR in
Table 1. Results of the semi-quantitative analysis of the phantom studies.
actual SBR measured SBR
centre method left right measured/actual SBR (%)a
Berlin no AC 5.47 2.30 2.09 40.1
CT-based 5.47 2.55 2.37 45.0
Chang 5.47 2.88 2.62 50.3
Leipzig no AC 5.74 2.57 2.36 42.9
CT-based 5.74 2.92 2.53 47.5
Chang 5.74 3.04 2.88 51.6
Rostock no AC 5.19 2.36 2.40 45.9
CT-based 5.19 2.60 2.64 50.5
Chang 5.19 2.85 2.86 55.0
mean no AC 43.062.9
CT-based 47.662.8
Chang 52.362.4
The specific-to-background ratio (SBR) was measured using the same whole striatum ROIs as in the patient studies (Fig. 1).
ameasured SBR: mean over left and right hemisphere.
doi:10.1371/journal.pone.0108328.t001
DaTscan: CT-Based Attenuation Correction
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the whole striatum and the caudate-to-putamen ratio (maximum
over both hemispheres) were not included, independent of the AC
method (asymmetry: p$0.415, caudate-to-putamen ratio: p$
0.179). The number of false classified patients was 8 for no AC and
9 for both CT-based and Chang AC.
2. Impact on visual scoring
Inter-rater agreement of the visual scoring of DAT availability
was higher (i) for the consensus scores compared to the scores of
individual raters and (ii) for the binary score compared to the 5-
score for DAT availability (Table 3). The impact of the AC
method was very small (Table 3).
Percent agreement of the visual score for DAT availability
between CT-based and Chang AC was 81.567.9% for the full 5-
score and 92.762.7% for the binary differentiation between
normal and reduced DAT availability (averaged over the 6
individual raters). The consensus scores of the two raters at each
centre showed very similar agreement of 83.366.5% for the 5-
score and 91.460.9% for the binary decision. Diagnostic accuracy
averaged over all raters was 81.763.2%, 81.564.9% and
79.661.7% for no AC, CT-based and Chang AC, respectively.
Diagnostic accuracy of the consensus was 83.361.9%, 83.961.6%
and 79.662.5%.
The AC method had no significant effect on the raters’ certainty
in the differentiation between reduced and normal DAT
availability (p = 0.922). However, there was a significant effect of
the status of DAT availability: the certainty of the visual scoring
was lower in patients with normal DAT availability (score
averaged over all raters and all AC methods: 2.4060.83 versus
1.2460.60 in patients with normal and reduced DAT availability,
p,0.0005).
Image quality appeared slightly reduced without AC
(score = 2.3660.54), but very similar for the two AC methods
(2.1660.44 and 2.2260.53 for CT-based and Chang AC,
p= 0.393).
Discussion
The present study compared CT-based AC and Chang AC for
dopamine transporter SPECT with I-123-ioflupane with respect to
both semi-quantitative and visual analysis. The same reconstruc-
tion algorithm with the same parameter settings was used with
both AC methods in order to simplify the interpretation of
observed differences in reconstructed images (as effects of AC), in
contrast to most previous studies which used Chang AC with
Figure 3. Bland-Altman plots comparing the SBR of the
caudate (a) and the putamen (b) between CT-based and Chang
AC (SBRs of both hemispheres were included independently,
i.e. n =124). Different scales were chosen for abscissae and ordinates
in a and b for display purposes. The horizontal continuous line
represents the mean difference, the dashed lines indicate the 95%
confidence interval. The given p-value corresponds to the one-sample t-
test for zero mean.
doi:10.1371/journal.pone.0108328.g003
Table 2. Results of the semi-quantitative analysis of the patient studies.
reduced DAT availability (n=40) normal DAT availability (n=22)
no AC CT-based Chang no AC CT-based Chang
SBR caudate 1.8560.75 2.0360.71 2.4260.83 3.0160.51 3.1560.54 3.6760.65
SBR putamen 0.8060.41 0.9660.44 1.0760.46 1.6460.21 1.8960.26 2.0060.25
SBR striatum 1.3360.57 1.5160.57 1.7860.65 2.3660.35 2.5460.39 2.9160.45
caudate-to-putamen ratio 2.6760.84 2.3760.61 2.5360.64 1.9360.30 1.7560.23 1.9160.28
asymmetry caudate (%) 15.17611.95 14.92612.19 12.59610.82 7.0666.14 6.9565.53 6.5265.87
Asymmetry putamen (%) 23.28624.18 20.50615.81 18.82616.84 9.1167.91 7.1567.81 9.0668.29
asymmetry striatum (%) 15.92612.94 15.43611.58 13.35610.65 5.6565.13 6.0064.55 5.2865.15
Given are mean values 61 standard deviation (minimum over both hemispheres for the SBRs, maximum over both hemispheres for the caudate-to-putamen ratio).
Subjects were categorized as ‘reduced’ or ‘normal’ DAT availability according to the written report in the patient’s file.
doi:10.1371/journal.pone.0108328.t002
DaTscan: CT-Based Attenuation Correction
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filtered backprojection whereas CT-based AC was implemented
within an iterative reconstruction algorithm [24–26]. It is well
known that the reconstruction algorithm itself, in this case iterative
reconstruction versus filtered backprojection, has an impact on the
SPECT images. In the present study, the 3D ordered-subset
expectation-maximisation algorithm ‘Flash-3D’ was used with the
same number of subsets (15) and iterations (6) in all cases. This
might have introduced a systematic effect not directly related to
AC, since the speed of convergence of iterative reconstruction
depends on whether attenuation is modelled or not. However, this
effect is expected to be rather small in the present setting and,
therefore, was neglected.
Concerning the results of the semi-quantitative analysis in the
present study, CT-based AC resulted in intermediate SBRs about
half way between no AC and Chang AC. However, the differences
were rather small. For example, the increase of the SBR of the
whole striatum by CT-based AC compared to no AC was only
about 12% in the phantom studies (Table 1). This is explained by
the fact that (i) the effect of photon attenuation is considerably
smaller in I-123-ioflupane SPECT than in brain PET, due to the
shorter path length to be covered by the single photon in SPECT
compared to the total path length of both photons in PET which
overcompensates the higher attenuation coefficient in SPECT,
and that (ii) the effect of attenuation cancels to some extent during
the computation of the SBRs as uptake ratios.
The phantom studies demonstrated strong underestimation of
the actual SBR between about 48% (Chang AC) and about 57%
(no AC) in the reconstructed SPECT images. Simulation showed
that this can be explained by partial volume effects to large extent
(Fig. 5). The effect of photon attenuation is rather small compared
to the partial volume effects.
Assuming that iterative reconstruction modelling attenuation
using the CT-based attenuation map provides more accurate
correction of photon attenuation in the brain than Chang AC, the
latter being based on a strongly simplified model, the results of the
present study suggest that Chang AC overestimates attenuation of
photons originating from the striatum relative to the attenuation of
photons from the reference region. To some extent this might be
explained by the use of the narrow-beam LAC m=0.148 cm21 for
both Chang and CT-based AC, which might be too large, if
scatter correction is incomplete. However, Chang AC resulted in
larger SBRs than CT-based AC even with LAC as low as
m=0.10 cm21 (LAC for CT-based AC fixed at m=0.148 cm21).
Warwick and co-workers also found larger SBRs in dopamine
transporter SPECT with Chang AC than with CT-based AC, at
least in the patient scans included in their study [35]. Rajeevan
et al. evaluated non-uniform AC based on transmission imaging
for I-123-b-CIT and concluded that both non-uniform and
uniform AC provide a small improvement of semi-quantitative
analysis compared to no AC [36].
The effect of the AC method on left/right asymmetry was small
(Table 2). This can be explained by the definition of left/right
asymmetry as the difference of SBRs within a ROI and its mirror
ROI. Effects of AC cancel, because attenuation characteristics are
essentially the same in both hemispheres. The effect on the
caudate-putamen ratio was also small, which is explained by
similar arguments.
Concerning the diagnostic value of the considered semi-
quantitative parameters, the putamen SBR provided the best
differentiation between normal and reduced DAT availability
(with the written report in the patient’s file as gold standard) [37].
The effect of AC was again negligible.
Figure 4. ROC curves for the differentiation between reduced and normal DAT availability by the SBR of the caudate (a) and the
putamen (b) (minimum over both hemispheres).
doi:10.1371/journal.pone.0108328.g004
Table 3. Cohen’s unweighted k (mean 61 standard deviation) for inter-rater agreement of visual scoring of DAT availability.
individual raters consensus scores
(15 pairs of raters) (3 pairs of consensi)
no AC CT-based Chang no AC CT-based Chang
5-score 0.7160.11 0.7060.10 0.7260.09 0.8060.14 0.7860.04 0.8060.06
binary score 0.7360.13 0.7760.12 0.7660.11 0.9060.05 0.8260.02 0.8160.06
doi:10.1371/journal.pone.0108328.t003
DaTscan: CT-Based Attenuation Correction
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The lack of an impact of AC on the diagnostic power of I-123-
ioflupane SPECT was confirmed by the results of the visual
interpretation of the SPECT images. Neither the scores of the 6
individual raters nor the consensus scores obtained at each centre
showed an effect of AC on their diagnostic value. This finding is in
agreement with the results of Bienkiewicz and colleagues who
Figure 5. SPECT underestimates the true activity concentration in small structures such as the striatum and its substructures due to
the limited spatial resolution in the reconstructed SPECT image (partial volume effect, PVE). In order to estimate the extent of
underestimation in the present study, the reconstructed spatial resolution was estimated on the basis of a line source measurement using the same
acquisition and reconstruction protocol as in the measurements of the striatal phantom and the patients included in the present study (no AC).
Spatial resolution was found to be about 8 mm full-width-at-half-maximum (FWHM). Then a high-resolution CT of the striatal phantom was
segmented manually (top row; from left to right: transversal, sagittal and coronal slice). Voxel values in the striatum were set to 6.5, voxel values in the
background to 1.0 in order to simulate the actual SBR of about 5.5 in the phantom studies (Table 1). Then the segmented CT image was smoothed
with a 3-dimensional Gaussian kernel with 8 mm FWHM to simulate the PVE in SPECT (bottom row). ROI analysis of the smoothed image resulted in a
striatal SBR of 3.2 which underestimates the actual SBR of 5.5 by about 42%.
doi:10.1371/journal.pone.0108328.g005
Figure 6. Image quality. Slab of 12 mm thickness of the scaled, stereotactically normalized I-123-ioflupane SPECT averaged over all patients with
normal DAT availability (top). Slab displaying the coefficient of variation (%) of the DVR over all patients with normal DAT availability (bottom).
doi:10.1371/journal.pone.0108328.g006
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compared Chang AC (with filtered backprojection) and CT-based
AC (with iterative OS-EM reconstruction) in I-123-ioflupane
SPECT with respect to visual evaluation by a single reader and
found no sigificant effect [38].
Agreement of the retrospective binary consensus score with the
classification of DAT availability in the written report ranged
between 79.6% and 83.3%, which appears rather low. The most
frequent discrepancy was that a scan which had been classified as
normal in the written report was scored as reduced in the
retrospective visual analysis, indicating somewhat more sensitive
reading in the restrospective analysis. This might be explained, at
least in part, by the fact that only anonymized SPECT images
were provided for the restrospective visual reading (Fig. 2),
whereas clinical data and semi-quantitative analysis of the I-123-
ioflupane uptake had been available in addition to the SPECT
images for the classification in the written report in the patient’s
file. Furthermore, retrospective visual reading was based on a
standardized documentation page presenting exactly the same
slices in each individual patient with a fixed, predefined colortable
(Fig. 2), whereas there is variation of slice orientation and
colortable in visual analysis of SPECT images in clinical routine.
In addition to accuracy, stability is an important attribute of any
diagnostic procedure in clinical routine patient care. In case of
radionuclide imaging, variability in the interpretation of the
images between different readers is most likely the limiting factor
rather than variability of tracer uptake between different scans of
the same patient [39]. The present study demonstrated very good
to excellent inter-rater agreement of visual reading, particularly for
the binary differentiation between normal and reduced DAT
availability, which is more relevant clinically than grading the
reduction of DAT availability using the 5-score based on Benamer
et al. [31]. Inter-rater agreement in this study was comparable to
results reported by Kahraman and colleagues [40]. The effect of
AC on inter-rater agreement was negligible (Table 3).
AC also had no impact on the certainty of visual differentiation
between normal and reduced DAT availability. Only the status of
DAT availability had an effect: the certainty was significantly
higher in patients with reduced DAT availability than in patients
with normal DAT availability, as direct consequence of the
instruction given to the raters to interpret the SPECT images
conservatively, as in clinical routine patient care where it is
important to keep the rate of false positive results low.
Finally, the method for AC, i.e. CT-based versus Chang, also
had no significant effect on image quality. Image quality appeared
slightly worse without AC, most likely because of apparently
increased tracer uptake outside the brain which somewhat
complicates the identification of the brain (Fig. 6).
The following limitations of the present study should be noted.
First, the diagnosis in the original report was used as gold standard
for the evaluation of diagnostic accuracy, because a final clinical
diagnosis based on follow-up was not available. However, we do
not consider this as a major limitation, since the gold standard
mainly affects the absolute value of the diagnostic accuracy.
Relative diagnostic accuracy is much less affected. The statement
that the impact of attenuation correction (with versus without) and
the impact of the AC method (CT-based versus Chang) on
diagnostic accuracy is negligible, therefore, is not affected. In
addition, semi-quantitative analyses (Bland-Altman plots) as well as
percent agreement, certainty and image quality according to the
visual reading are also not affected by the gold standard.
Second, Chang attenuation correction is a post reconstruction
method, i.e. the correction is performed by voxelwise multiplica-
tion of the SPECT image reconstructed without attenuation
correction with a correction image calculated for a constant
attenuation coefficient within the head contour according to
Chang [18]. Now, the simplified m map consisting in a constant
value within the head contour might also be used for modelling
attenuation within the iterative reconsruction instead of the
attenuation map derived from the low-dose CT. It would be
interesting to check whether this approach further reduces the
difference of SBRs between CT-based AC and AC based on a
uniform m map. However, whereas there might be an effect on
absolute values of SBRs, we do not expect an effect on diagnostic
value of I-123-ioflupane SPECT, because there is already no
difference between CT-based AC and post reconstruction Chang
AC with respect to diagnostic value.
Conclusion
CT-based attenuation correction was compared with Chang
attenuation correction with respect to its impact on the diagnostic
accuracy of visual and semi-quantitative analysis as well as on
inter-rater variability of visual image interpretation in I-123-
ioflupane SPECT. These measures are more relevant in clinical
routine patient care than absolute quantitative accuracy, as the
objective is the discrimination between healthy and diseased state
rather than accurate measurement of the density of dopamine
transporters (for example in fmol/ml).
The impact of CT-based attenuation correction on the visual
interpretation and the diagnostic value of semi-quantitative
analysis of I-123-ioflupane SPECT was found to be negligible.
Therefore, CT-based attenuation correction cannot be recom-
mended for routine use, not least because of the additional
radiation exposure caused by the low-dose CT.
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